Scientists have announced the invention of a genetic testing technology that allows the number of clinical biomarkers to be analyzed at the single-molecule level, which enhances the sensitivity of tests in precision medicine and will make them more affordable in future. The TAC-seq method, for which a patent is pending, is already being used in fertility clinics to determine the personal variations in the menstrual cycle for opportune embryo transfer.
from Latest Science News -- ScienceDaily https://ift.tt/2A3jahg
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment